Background The albumin-indocyanine green evaluation (ALICE) model based on serum albumin and indocyanine retention rate has been shown to be an effective method for predicting postoperative outcomes in hepatocellular carcinoma patients. Aim of the study was to validate the ALICE model in a large Western cohort of patients by comparing the albumin-bilirubin (ALBI) score and ChildTurcotte-Pugh (CTP) score. Methods A total of 400 patients who underwent hepatic resection from January 2005 to June 2016 at three centers were enrolled. The ALICE, ALBI, and CTP scores were computed for all patients. Results The ALICE score correlated better with ALBI (r = 0.428) than with CTP score (r = 0.302). Both the ALICE (grade 1: 49%; grade 2: 51%) and the ALBI (grade 1: 52.5%; grade 2: 47.5%) scores stratified the CTP class A patients into two distinct classes. The incidence of ascites (grades 1-3: ALICE 11%, 20%, 58%; ALBI 11%, 23%, 50%) and severe liver failure (ALICE 8.7%, 10.5%, 41.7%; ALBI 8.6%, 12%, 50%) increased with increasing ALBI and ALICE grade and were similar for the same grade.
Introduction
The majority of patients who are treated for hepatocellular carcinoma (HCC) have two pathologies: neoplastic disease and underlying liver disease [1] . In contrast to most solid tumors, both postoperative outcomes and prognosis of patients with HCC are influenced not only by the extent of anatomic spread of the cancer but equally, if not more importantly, by the degree of functional impairment. For this reason, preoperative selection in this patient population is as critical as it is complex. A wide variety of prognostic and therapeutic algorithms that take into account clinical data shown to be associated with worse clinical outcomes have been proposed. The Barcelona Cl ınic Liver Cancer (BCLC) model [2] , the most common standard used in Western counties, quantifies liver functional status using the Child-Turcotte-Pugh (CTP) score. Measurement of the indocyanine green retention rate at 15 min (ICGR 15 ) has been largely used in Eastern countries, as shown in the Japanese Society of Hepatology algorithm [3, 4] . Recently, two new scores have been proposed for the prediction of outcomes in patients with HCC: the albumin-bilirubin (ALBI) score [5] and the albumin-indocyanine green evaluation (ALICE) score [6] . The ALBI score, computed only with albumin and bilirubin levels, has been established as a useful prognostic model in 2,584 Japanese HCC patients treated at two different institutions [5] . It has subsequently been validated by multi-institutional cohorts of patients from different geographic regions, with different etiologies and scheduled for different treatments [7] [8] [9] and seems able to predict postoperative liver failure in patients with HCC [10] [11] [12] . The ALICE score was proposed by an Eastern group [6] and incorporates only two preoperative variables, namely the serum albumin level and the ICGR 15 value, whereby their effect on the overall survival of more than 1,800 patients treated for HCC was evaluated. According to the equation for the linear predictor, the authors identified three ALICE grades. Determination of the ALICE grade allowed a reasonable prediction of the risk of postoperative ascites and mortality, and good stratification of the overall survival. The aim of this study was to validate the ALICE model in a Western cohort of patients, comparing the ability of ALICE to predict postoperative outcomes with CTP and ALBI scores.
Methods
All patients with HCC who underwent hepatic resection from January 2005 to June 2016 at three tertiary centers (Mauriziano Hospital, Turin; University of Verona; Universit a Cattolica del Sacro Cuore, Rome) were analyzed. For all patients, ALICE, ALBI, and CTP scores were calculated. Cases with missing data for the computation of the scores were excluded. The characteristics of development cohort [6] were analyzed and compared with our validation cohort. In particular, data on sex, age, period of recruitment, and liver function (albumin level, ICGR 15 value, CHILD score and ALICE grade) of the two cohorts were described. Subsequently, the ability to predict postoperative outcomes of the ALICE model was analyzed. ALICE model performance was compared with ALBI and CTP scores. Furthermore, the ability of the scores to predict postoperative outcomes was tested separately for patients who underwent minor and major resections. Finally, postoperative outcomes of patients with discordant grade of ALICE and ALBI (for example, ALICE grade 2 with ALBI 1 or ALICE grade 2 with ALBI 3 grade) were compared. The collection and registration of the original database was performed according to the regulations and with the approval of institutional review board IRB 11-368.
Patient management
Diagnoses of HCC and cirrhosis were based on histological evidence after surgery.
Indications for the treatment of patients with HCC were defined according to the evidence-based clinical practice guidelines for hepatocellular carcinoma of the Japan Society of Hepatology [3, 4] . The presence of macroscopic vascular invasion, portal hypertension, and CTP class B score was not considered as absolute contraindications for surgical resection in all three centers. The extent of hepatectomy required was evaluated according to the extent of disease progression, the liver function status, and the general condition of the patient (i.e. Makuuchi criteria) [13] . The ICGR 15 value was measured within 3 months before surgery. In patients who underwent portal vein embolization, the ICGR 15 value after portal vein embolization was used for the analysis. After taking a basal blood sample, indocyanine green (Pulsion Medical Systems, Munich, Germany) at a dose of 0.5 mg/kg was administered via the antecubital vein of the opposite arm. The rate of serum ICGR 15 was non-invasively evaluated using a liver function monitoring system (LIMON; Pulsion Medical Systems) in Verona center. In the other two centers, venous peripheral blood samples were collected every 5 min for 15 min. ICGR 15 values were calculated by fitting the serum disappearance curve by a single exponential decay equation.
Calculation of scores
The CTP score was calculated using total bilirubin, albumin, prothrombin time, and clinical findings of encephalopathy and ascites [14] . The CTP categories were defined as: grade A, 5-6 points; grade B, 7-9 points; and grade C, 10-15 points. The ALICE score was calculated by means of the formula 0.663 9 log 10 ICGR 15 (%) À 0.0718 9 albumin (g/L). The ALICE score was stratified as ALICE grade 1, linear predictor value ≤À2.20; ALICE grade 2a, linear predictor value À2.20 to ≤À1.88; ALICE grade 2b, linear predictor value >À1.88 to ≤À1.39; ALICE grade 3, linear predictor value >À1.39. The ALBI score was calculated by means of the formula 0.66 9
The ALBI score was stratified as ALBI score ≤À2.60 (ALBI grade 1), >À2.60 to ≤À1.39 (ALBI grade 2), and >À1.39 (ALBI grade 3).
Definitions
Macroscopic vascular invasion was defined as tumor thrombosis in the second-order branch and/or the first-order branch of the portal vein or major hepatic vein, according to the Japanese staging system [15] . Portal hypertension was defined as the presence of esophageal varices and/or a platelet count of <100,000/ll in association with splenomegaly [16] . According to Brisbane terminology, major hepatectomy was defined as the resection of at least three Couinaud's segments and minor resection was defined as the resection of <3 Couinaud's segments [17] . Morbidity included all postoperative complications and was classified according to the Dindo classification [18] . Complications of grade III or higher were defined as major morbidity. Postoperative liver failure was defined as an increased international normalized ratio and concomitant hyperbilirubinemia ≥5 days postoperatively [19] . The liver failure of grade B and C was defined as severe liver failure and was considered a major complication. Postoperative mortality was defined as death within 90 days after liver resection.
Statistical analysis
All statistical analyses were performed with IBM SPSS Italy (v20.0). Categorical variables were compared using the chi-squared test, Fisher's exact test, or Pearson's test as appropriate. Continuous variables were compared using unpaired t-tests or Mann-Whitney U-tests as appropriate. Pairwise comparisons were performed using Dunn's (1964) procedure with a Bonferroni correction for multiple comparisons in cases of significant differences observed among the three groups. Adjusted P-values are presented. The differences between categorical variables were assessed using the v 2 test of homogeneity (29c). Post hoc analysis involved pairwise comparisons using multiple Fisher's exact tests (2 9 2) with a Bonferroni correction. A Mantel-Haenszel test of trend was run to determine whether a linear association existed between ALICE, CTP, and ALBI scores.
Results

Patient characteristics and comparison with the development cohort
The study population comprised 400 patients with a median age of 70 years. Portal hypertension was present in 16% of patients. The etiology of cirrhosis was related to hepatitis C virus in almost 40% of patients. The median value of the ICGR 15 test was 11. The majority of patients in the study were in BCLC class A. The proportion of patients in BCLC class B and C amounted to 13% (52 out of 400) and 17% (68 out of 400), respectively. As expected, only 3.7% of patients were in CTP class B. Regarding the ALICE classification, about half of the patients were grade 1 and only 3% grade 3. Finally, the proportion of patients in ALBI grades 1, 2, and 3 amounted to 52%, 47%, and 1%, respectively. Regarding surgical data, an extended resection was performed in 13 (3.3%) patients, a major hepatectomy in 88 (22%) patients 2 (1) = 16.52, P < 0.001, r = 0.204). Finally, the strongest relationship was found between ALICE and ALBI scores (v 2 (1) = 72.960, P < 0.001, r = 0.428). The higher ALICE grade was associated with higher ALBI class, and vice versa. Table 1 shows the number of patients for each cell combination between ALICE, ALBI, and CTP classes.
Postoperative outcomes
Nine (2.2%) patients died during the postoperative course ( Table 2 ). Postoperative complications occurred in 176 (44%) patients and 39 (9.7%) patients with grade 3-4 according to Dindo classification. Eighty-two (20.5%) patients experienced liver failure (grades B and C in 41.5% of cases). Mortality was related to liver failure in 5 of 9 (55.6%) patients. Median blood loss during parenchymal transection was 270 ml, 250 ml and 320 ml in ALICE 1/2/3 patients; 260 ml, 280 ml, 800 ml in ALBI 1/2/3 patients and 270 ml, 220 ml and 440 ml in CTP A5/A6/B7 patients.
The ALICE model allowed the stratification of patients according to the risk of overall morbidity (grade 1/2: 45%; grade 3: 75%), ascites (grade 1: 11%; grade 2: 20%; grade 3: 58%), liver failure (grade 1: 15%; grade 2: 24%; grade 3: 50%), and liver failure grades B and C (grade 1: 8.7%; grade 2: 10.5%; grade 3: 41.7%). No differences were found between ALICE 2a and 2b patients. Patients with ALBI 2 had a higher risk of ascites (22.9% vs. 11.1%) and severe liver failure (12.1% vs. 8.6%) rates compared with ALBI 1 patients. CTP B patients showed a higher percentage of overall morbidity (86.7% vs. 42.3%), liver failure (46.7% vs. 19.5%), liver failure grades B and C (30.8% vs. 10.1%), and ascites (46.7% vs. 15.8%) compared with CTP A patients. No differences were found between CTP A5 and A6 patients. Finally, patients with CTP B with ALICE grade 1 or ALBI grade 1 experienced no postoperative liver failure.
The ability of the scores to predict overall morbidity and severe liver failure was tested separately for patients who underwent major (n = 101, Table 3 ) and minor resections (n = 299, Table 4 ). The rate of severe liver failure significantly increased with ALICE grade, both after minor resection (ALICE grade 1/2/3 2.8%, 4.7% and 25%, P = 0.011) and major resection (ALICE grade 1/2/3 14%, 23.4% and 75%, P = 0.013). Similar results were found using ALBI score.
The postoperative outcomes of patients with discordant grade of ALICE and ALBI were compared. Patients with ALICE grade 1 and ALBI grade 2 (n = 27) and those with ALBI albumin-bilirubin, ALICE albumin-indocyanine green evaluation, CTP Child-Turcotte-Pugh In bold significant P-value ALICE grade 2 and ALBI grade 1 (n = 44) had similar overall morbidity (37% vs. 36.4%) and severe liver failure rates (7.4% vs. 6.8%). The only significant differences were found inside ALBI 2 patients with discordant ALICE grade. In particular, ALBI 2 patients with grade 3 ALICE (n = 9) had a significantly higher percentage of overall morbidity (77.8% vs. 35.7%, P = 0.028), postoperative liver failure (44.7% vs. 10.7%, P = 0.025), liver failure grade B and C (33.3% vs. 7.1%, P = 0.046), compared with ALBI 2 patients with grade 1 ALICE (n = 28).
Discussion
Assessment of liver function before resection is crucial in order to exclude patients with too high an operative risk Table 3 Overall morbidity and severe liver failure rates of patients undergoing major liver resection according to ALICE, ALBI, and CTP grades ALBI albumin-bilirubin, ALICE albumin-indocyanine green evaluation, CTP Child-Turcotte-Pugh In bold significant P-value Table 4 Overall morbidity and severe liver failure rates of patients undergoing minor liver resection according to ALICE, ALBI, and CTP grades ALBI albumin-bilirubin, ALICE albumin-indocyanine green evaluation, CTP Child-Turcotte-Pugh In bold significant P-value (mainly postoperative liver failure) and to plan surgery whose extension is tailored to liver parenchyma functionality [12, 20] . The standard assessment tools for hepatic function in HCC patients are the CTP score [2] and ICGR 15 test [3] . However, for both methods some issues exist. CTP classification includes subjective (ascites, hepatic coma) factors and uses a cutoff point for continuous variables not constructed in a statistical manner. ICGR 15 requires injection of indocyanine and is not widely available in clinical practice, even though new non-invasive bedside monitors (pulse dye densitometry technology) make this opportunity easier. Recently, two new scores have been proposed as a means of overcoming the limitation of Child-Pugh classification: the ALBI score [5] and the ALICE score [6] . ALBI score, computed only with albumin and bilirubin levels, seems able to predict postoperative liver failure in patients with resected HCC [10] [11] [12] . The ALICE score [6] is based on the serum albumin level and the ICGR 15 value. In the development cohort in whom ALICE was tested [6] , it was able to predict postoperative risk of overall morbidity and ascites.
In this study, we assessed the performance regarding prediction of postoperative outcome by the ALICE score in comparison with CTP and ALBI scores, focusing on a large nationwide cohort of patients who underwent liver resection. The ALICE system is equally effective in predicting postoperative complications and ascites in our validation cohort when compared with the development cohort [6] . The score failed to predict postoperative mortality, probably because of the small number of events. Nevertheless, predicted liver failure that was not evaluated by Eastern authors.
The CTP model stratified more than 80% of the patients into the same risk class (i.e. the best one, CTP A5) and only a minimal number in the remaining CTP A6 and B classes. By contrast, both ALICE and ALBI scores recognized the best performing classes (grades 1 and 2) each with around 40%-45% of patients, with the remainder in the highest risk class (grade 3). These data reflect one of the major limits of the CTP score, namely that within the CTP class A, there is a wide variation in the degree of hepatic reserve [21, 22] . Our data showed that the CTP A patients could be successfully reclassified into two subgroups according to both ALICE and ALBI scores. At the same time, patients within CTP class B with grade 1 ALICE or ALBI scores had better functionality. In line with this result, none of these patients developed postoperative liver failure. Similar data on ALBI ability were previously reported by several authors [10] [11] [12] . To our knowledge, this is the first study comparing the performance of the ALICE and ALBI scores. Hiraoka et al. [11] showed that the ALBI score correlated well with ICGR 15 . It is therefore not surprising that a test of trend showed a good correlation between ALBI and ALICE scores. In addition, the incidence of liver failure and ascites increased with increasing ALBI and ALICE grade and was similar at the same grade, both in the entire cohort and in a subset of patients treated with minor resection. Finally, patients with ALBI scores of grades 1, 2, and 3 showed a distribution of ICGR 15 levels similar to that of patients with ALICE grades 1, 2, and 3, respectively, below 10%, between 10% and 20%, and higher than 20% (data not shown). These data can be used for the application of the Makuuchi criteria [13] .
Clearly, obtaining ICGR 15 value is more complex and time-consuming than ALBI value. However, our results showed that ALICE model allows to stratify patients within ALBI grade 2 by recognizing increasing risk classes. In our opinion, data provided by ALICE model are more exhaustive. Therefore, ALICE model could be the preferred score in patients scheduled to high-risk surgery (e.g. major hepatic resections). In contrast, ALBI model could be adequate in patients who are candidates for low-risk surgery or nonsurgical treatments.
The present study carries some limitations related to its retrospective nature. First, the fact that the extent of liver resection was based on the ICGR 15 value and the Makuuchi criteria may have led to bias in our results. Second, the perioperative mortality rate in this study was low. The relationship between the ALICE score and the mortality risk during liver resection needs to be verified in further large studies. Surprisingly, ALICE 1 patients undergoing major hepatectomy developed higher overall morbidity rate of ALICE 2 patients, even if the difference was not statistically significant. On the other hand, severe liver failure rate was correctly stratified. Further studies with a greater number of major hepatectomy are needed to confirm or refute these data. The ICG values were calculated by the invasive method in two centers and with LIMON method in one. LIMON method has been reported to constantly underestimate the real ICG value [23] . In contrast, Purcell et al. [24] reported that even if the LIMON values were, on average, slightly lower than those obtained by spectrophotometry this difference is unlikely to be clinically relevant. Lacking clear evidence, no adjustments were made on ICG value in our study. Finally, as all of the subjects in this study underwent liver resection, definitive conclusions cannot be drawn regarding the ability of the ALICE score in identifying adverse outcomes in HCC patients scheduled for non-surgical treatment.
Conclusions
The ALICE model is effective in predicting postoperative complications, ascites, and liver failure, and is useful for further stratification of patients in CTP classes A and B. The ALICE grade can assess hepatic functional reserve in patients scheduled for liver resection with efficacy comparable with that of the ALBI grade and better than the CTP score.
